Feature Channels: Vision

Filters close
Released: 28-Apr-2017 3:00 PM EDT
NEI’s Healthy Vision Month 2017 Puts Spotlight on Women
NIH, National Eye Institute (NEI)

May is Healthy Vision Month when the National Eye Institute (NEI) encourages everyone to make eye health a priority. This message is especially important for women, who make up two-thirds of all people living with blindness or visual impairment from diseases such as age-related macular degeneration (AMD), glaucoma, and cataract.1 Among women age 40 and older in the U.S., 2.7 million are blind or visually impaired.2

Released: 27-Apr-2017 3:00 PM EDT
Artificial Intelligence Shows Potential to Fight Blindness
American Academy of Ophthalmology (AAO)

Researchers from the Byers Eye Institute at Stanford University have found a way to use artificial intelligence to fight a complication of diabetes that affects the eyes.

   
27-Apr-2017 12:00 PM EDT
Findings Suggest Underdiagnoses of Age-Related Macular Degeneration
University of Alabama at Birmingham

Approximately 14 million Americans have age-related macular degeneration, and a new study suggests it may be underdiagnosed in primary eye care settings.

Released: 21-Apr-2017 3:05 PM EDT
New Research Can Help Find Solutions to the Challenge of Glaucoma in Developing Countries
Glaucoma Research Foundation

Glaucoma in developing countries represents a significant health crisis. The great majority of people in developing countries aren’t ever tested for glaucoma, so diagnosis and treatment are rare. And if they are diagnosed, they often can’t pay for medication, assuming medications are available.

17-Apr-2017 4:50 PM EDT
Using CRISPR to Reverse Retinitis Pigmentosa and Restore Visual Function
UC San Diego Health

Using the gene-editing tool CRISPR/Cas9, researchers at University of California San Diego School of Medicine and Shiley Eye Institute at UC San Diego Health, with colleagues in China, have reprogrammed mutated rod photoreceptors to become functioning cone photoreceptors, reversing cellular degeneration and restoring visual function in two mouse models of retinitis pigmentosa.

Released: 19-Apr-2017 7:00 AM EDT
Powered by CIRM Grant, jCyte Launches New Clinical Trial
jCyte

Cell-based therapy company jCyte is launching a Phase 2b clinical trial to study the effectiveness of its developmental therapy for retinitis pigmentosa.

Released: 17-Apr-2017 3:45 PM EDT
Eye Expressions Offer a Glimpse Into the Evolution of Emotion
Cornell University

New research by Adam Anderson, professor of human development at Cornell University’s College of Human Ecology, reveals why the eyes offer a window into the soul. According to the recent study, in Psychological Science, we interpret a person’s emotions by analyzing the expression in their eyes – a process that began as a universal reaction to environmental stimuli and evolved to communicate our deepest emotions.

   
Released: 17-Apr-2017 8:00 AM EDT
Cave-In: How Blind Species Evolve
Arizona State University (ASU)

Why do animals that live in caves become blind? Charles Darwin originally suggested that eyes could be lost by “disuse” over time. Now, Reed Cartwright, an ASU evolutionary biologist in the School of Life Sciences and researcher at the Biodesign Institute, wants to get to the heart of the matter—and in a recent publication in the journal BMC Evolutionary Biology, may be proving Darwin wrong.

Released: 12-Apr-2017 6:05 PM EDT
Making Prosthetic Eyes That Look Like the Real Thing
Michigan Medicine - University of Michigan

Thanks to Greg Dootz, an ocularist at the University of Michigan’s Kellogg Eye Center, more than 3,000 patients have received prosthetic eyes that are every bit as beautiful — and complex — as the real thing.

Released: 11-Apr-2017 2:05 PM EDT
Tunable Electric Eyeglasses Bend to the Will of the Wearer
National Institute of Biomedical Imaging and Bioengineering

Engineers funded by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed glasses with liquid-based lenses that “flex” to refocus on whatever the wearer is viewing.

5-Apr-2017 10:10 AM EDT
Researchers Identify New Target for Abnormal Blood Vessel Growth in the Eyes
Massachusetts Eye and Ear

A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization, or abnormal blood vessel growth in the retina, a hallmark of advanced diabetic eye disease (proliferative diabetic retinopathy). According to a report published online in Diabetes, the transcription factor RUNX1 was found in abnormal retinal blood vessels, and by inhibiting RUNX1 with a small molecule drug, the researchers achieved a 50 percent reduction of retinopathy in preclinical models.

3-Apr-2017 8:05 AM EDT
Why Did We See “The Dress” Differently? The Answer Lies in the Shadows, Neuroscience Research Finds
New York University

When “the dress” went viral in 2015, millions were divided on its true colors: gold and white or black and blue? In a new study, an NYU neuroscientist concludes that these differences in perception are due to our assumptions about how the dress was illuminated.

6-Apr-2017 12:00 AM EDT
Honey Bees Have Sharper Eyesight Than We Thought
University of Adelaide

Research conducted at the University of Adelaide has discovered that bees have much better vision than was previously known, offering new insights into the lives of honey bees, and new opportunities for translating this knowledge into fields such as robot vision.

Released: 5-Apr-2017 3:05 PM EDT
Newly Discovered Chemical Reaction in Eye May Improve Vision
Case Western Reserve University

A light-sensing pigment found in everything from bacteria to vertebrates can be biochemically manipulated to reset itself, an important therapeutic advantage, according to new research out of Case Western Reserve University School of Medicine.

Released: 4-Apr-2017 9:05 PM EDT
NUS Engineers Develop Novel Lens for Super-Resolution Imaging
National University of Singapore (NUS)

A team of researchers from the National University of Singapore's Faculty of Engineering has developed a novel lens for super-resolution imaging which breaks resolution limitations in microscopy and has potential applications in high precision failure inspection and biological research.

Released: 4-Apr-2017 1:30 PM EDT
Marker May Help Predict Success with Extended-Wear Contact Lenses
Wolters Kluwer Health: Lippincott

A simple marker on eye examination may help vision care professionals predict which patients will have a higher or lower rate of problems after starting extended-wear contact lenses, reports a study in the April issue of Optometry and Vision Science, the official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

Released: 3-Apr-2017 9:00 AM EDT
How People who are Visually Impaired Can Walk the Monday Mile
Monday Campaigns

In honor of AHA’s National Walking Day on April 5, Dr. Laura Sperazza, Director of Low Vision Services at Lighthouse Guild in NY, offers tips for walking a Monday Mile for individuals with low vision. The Monday Mile, an initiative of The Monday Campaigns, encourages people from all walks of life to walk for their health by using Monday as the starting day.

Released: 31-Mar-2017 10:05 AM EDT
Helping the Retina Regenerate
NIH, National Eye Institute (NEI)

A new report gives recommendations for regenerating retinal ganglion cells (RGCs), crucial neurons in the back of the eye that carry visual information to the brain.

Released: 30-Mar-2017 5:05 PM EDT
Researchers Find New Genetic Links Underlying Progressively Blinding Eye Disease
UC San Diego Health

Researchers at University of California San Diego School of Medicine, with colleagues at Case Western University, Duke University, the National Institutes of Health and elsewhere, have identified three novel genomic loci — distinct stretches of genetic material on chromosomes — linked to Fuchs endothelial corneal dystrophy (FECD), which often clusters in families and is roughly 39 percent heritable.

Released: 30-Mar-2017 2:00 PM EDT
New Clinical Trial for Early-Stage Eye Melanoma Offers Study of Targeted Therapy
Wills Eye Hospital

A first-of-its-kind, potentially groundbreaking new option for treating a form of eye cancer is now in its first phase-1 clinical research trial at Wills Eye Hospital in Philadelphia.

   
Released: 30-Mar-2017 10:05 AM EDT
NIH-Funded Team Identifies Genetic Underpinnings of Fuchs Dystrophy
NIH, National Eye Institute (NEI)

An international study helps pinpoint the genetic risk factors associated with Fuchs endothelial corneal dystrophy, the most common disorder requiring corneal transplantation. The discovery of gene variants illuminates the biological mechanisms for the disorder, which affects 4 percent of people age 40 and older. The study appears in Nature Communications and was funded by the National Eye Institute, part of the National Institutes of Health.

Released: 29-Mar-2017 5:05 PM EDT
Dedicated Staff Keep Keen Eye on Early Detection of Diabetic Vision Loss
Harris Health System

Capturing high-resolution images of a patient's eye and retina are vital to ensure good vision for people with diabetes. It takes patience and attention to detail for ophthalmology technicians to produce high-quality images that trained experts at Harris Health System can use to spot vision loss/problems.

Released: 27-Mar-2017 11:50 AM EDT
NIH-Funded Scientists Home in on Molecular Causes of Secondary Cataract
NIH, National Eye Institute (NEI)

In a new study, scientists find that the growth factor TGF-beta may play a role in the formation of secondary cataract, suggesting a direction for research into strategies to prevent it. The study appears in Molecular Biology of the Cell and was funded by the National Eye Institute, part of the National Institutes of Health.

Released: 22-Mar-2017 2:50 PM EDT
Zinc in the Retina May Indicate A New Way to Protect and Regenerate the Optic Nerve in Glaucoma Patients
Glaucoma Research Foundation

Connecting pieces of information by finding a common thread often takes glaucoma researchers in unexpected directions. Zinc is one such thread that joined together different experts at Boston Children’s Hospital and Harvard Medical School.

17-Mar-2017 4:05 PM EDT
Brain “Rewires” Itself to Enhance Other Senses in Blind People
Massachusetts Eye and Ear

The brains of those who are born blind make new connections in the absence of visual information, resulting in enhanced, compensatory abilities such as a heightened sense of hearing, smell and touch, as well as cognitive functions (such as memory and language) according to a new study led by Massachusetts Eye and Ear researchers.

21-Mar-2017 1:35 PM EDT
Study Suggests New Way to Prevent Vision Loss in Diabetics and Premature Babies
The Rockefeller University Press

Researchers at Bascom Palmer Eye Institute, part of the University of Miami Miller School of Medicine, have identified a new molecule that induces the formation of abnormal blood vessels in the eyes of diabetic mice. The study, “Secretogranin III as a disease-associated ligand for antiangiogenic therapy of diabetic retinopathy,” which will be published March 22 in The Journal of Experimental Medicine, suggests that inhibiting this molecule may prevent similarly aberrant blood vessels from damaging the vision of not only diabetics, but also premature infants.

Released: 21-Mar-2017 5:00 PM EDT
ARVO Opposes Cuts to Medical Research Budget; Urges Increased Investment
Association for Research in Vision and Ophthalmology (ARVO)

The Association for Research in Vision and Ophthalmology (ARVO) urges Congressional leaders to reject the U.S. administration’s recent FY18 budget proposal, which seeks to drastically cut National Institute of Health funding by nearly $6 billion, or 20%. These cuts would be devastating to the current and future efforts of the eye and vision research community and to patients who desperately count on the efforts of researchers and clinicians to save their sight.

   
Released: 20-Mar-2017 12:05 PM EDT
A Pocket-Sized Retina Camera, No Dilating Required
University of Illinois Chicago

Researchers at the University of Illinois at Chicago College of Medicine and Massachusetts Eye and Ear/Harvard Medical School have developed a cheap, portable camera that can photograph the retina without the need for pupil-dilating eye drops.

Released: 15-Mar-2017 9:00 AM EDT
Pilot Eye Movements Change Noticeably By Two Hours In-Flight
SUNY Downstate Health Sciences University

A study published recently in the journal Psychology and Behavior unveils the potential to use changes in saccadic eye movements - the rapid repositioning of the eye to focus on a target - as a reliable biomarker for pilot fatigue. Professors Stephen Macknik, PhD, and Susana Martinez-Conde, PhD of SUNY Downstate Medical Center were co-authors in the study.

11-Mar-2017 12:00 PM EST
NIH-Funded Scientists Deploy CRISPR to Preserve Photoreceptors in Mice
NIH, National Eye Institute (NEI)

Silencing a gene called Nrl in mice prevents the loss of cells from degenerative diseases of the retina, according to a new study. The findings could lead to novel therapies for preventing vision loss from human diseases such as retinitis pigmentosa. The study was conducted by researchers at the National Eye Institute (NEI), part of the National Institutes of Health, and was published online today in Nature Communications.

Released: 13-Mar-2017 2:05 PM EDT
World Glaucoma Week 2017: Glaucoma Research Foundation Announces $1.3 Million in Research Grants
Glaucoma Research Foundation

Glaucoma Research Foundation (GRF) marked World Glaucoma Week today by announcing $1.3 million in research grants. Glaucoma Research Foundation is funding eight researchers at prestigious universities and medical research centers with one-year Shaffer Grants, as well as the four principal investigators engaged in the multi-year “Catalyst for a Cure” biomarker initiative.

Released: 13-Mar-2017 1:05 PM EDT
New Nano-Implant Could One Day Help Restore Sight
University of California San Diego

A team of engineers at the University of California San Diego and La Jolla-based startup Nanovision Biosciences Inc. have developed the nanotechnology and wireless electronics for a new type of retinal prosthesis that brings research a step closer to restoring the ability of neurons in the retina to respond to light. The researchers demonstrated this response to light in a rat retina interfacing with a prototype of the device in vitro.

Released: 13-Mar-2017 10:05 AM EDT
Breast Cancer Drug Dampens Immune Response, Protecting Light-Sensing Cells of the Eye
NIH, National Eye Institute (NEI)

The breast cancer drug tamoxifen appears to protect light-sensitive cells in the eye from degeneration, according to a new study in mice. The drug prevented immune cells from removing injured photoreceptors.

6-Mar-2017 5:05 PM EST
Fish Eyes May Hold Key to Regenerating Human Retinas
Vanderbilt University

Research into retinal regeneration in zebrafish has identified a signal that appears to trigger the self-repair process, raising the possibility that human retinas can also be induced to regenerate, naturally repairing damage caused by degenerative retinal diseases and injury, including age-related macular degeneration and retinitis pigmentosa.

   
9-Mar-2017 12:00 PM EST
NIH-Funded Study Helps Explain How Zebrafish Recover From Blinding Injuries
NIH, National Eye Institute (NEI)

Researchers at Vanderbilt University in Nashville, Tennessee have discovered that in zebrafish, decreased levels of the neurotransmitter gamma-aminobutyric acid (GABA) cue the retina, the light-sensing tissue in the back of the eye, to produce stem cells. The finding sheds light on how the zebrafish regenerates its retina after injury and informs efforts to restore vision in people who are blind.

Released: 8-Mar-2017 5:35 PM EST
Scientists Find Therapeutic Target for Diabetes-Related Blindness
Case Western Reserve University

Specific cells in the retina trigger inflammation and vision impairment associated with diabetes, according to new research out of Case Western Reserve University School of Medicine.

Released: 8-Mar-2017 4:05 PM EST
Pacific University (Ore.) to Dedicate its New EyeVan Mobile Clinic on Thursday at 2 p.m.
Pacific University (Ore.)

Pacific University's College of Optometry will dedicate its new EyeVan and for the ceremony and tours of the EyeVan.

Released: 8-Mar-2017 1:05 PM EST
Making Astronomy Accessible to the Blind
Associated Universities, Inc.

If intelligent life without sight exists on some distant planet in our galaxy, these lifeforms would still explore the universe; how? This is a guiding question for Innovators Developing Accessible Tools for Astronomy (IDATA), a new research initiative supported by the U.S. National Science Foundation.

7-Mar-2017 12:00 PM EST
In-Home Occupational Therapy Curbs Depression in Visually Impaired Patients
Johns Hopkins Medicine

Johns Hopkins researchers report that in-home occupational therapy appears to reduce the rate and severity of depression in people at higher risk for the disorder because of seriously impaired vision.

Released: 6-Mar-2017 1:05 PM EST
Fighting Blindness: TSRI Scientists Bring a Key Protein Into Focus
Scripps Research Institute

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have discovered how a protein called α2δ4 establishes proper vision.

Released: 3-Mar-2017 11:30 AM EST
Assessing the Impact of Stress in Age-Related Macular Degeneration
Wolters Kluwer Health: Lippincott

Age-related macular degeneration (AMD), the leading cause of vision loss among older adults in the United States, is often associated with psychological stress. A simple stress rating scale (the Perceived Stress Scale) is a valid and useful way to evaluate the connection between stress and progressive vision loss from AMD, according to a study in the March issue of Optometry and Vision Science, the official journal of the American Academy of Optometry. The journal is published by Wolters Kluwer.

Released: 3-Mar-2017 11:05 AM EST
Stem Cell Treatment May Restore Vision to Patients with Damaged Corneas
University of Georgia

Researchers have developed a new way to identify and sort stem cells that may one day allow clinicians to restore vision to people with damaged corneas using the patient’s own eye tissue.

Released: 1-Mar-2017 2:05 PM EST
New Micro-Pump Technology May Offer Glaucoma Patients an Alternative to Eye Drops
Glaucoma Research Foundation

It is no secret that the issues associated with current glaucoma medications can be problematic. Systemic medications carry the risk of side effects, while the current medical treatment of choice, eye drops, has its own drawbacks. Studies show that half of patients stop taking their prescription glaucoma eye drops after a year, leaving them vulnerable to vision loss

Released: 28-Feb-2017 3:20 PM EST
Does Pre-Eclampsia During Pregnancy Increase Risk to Mothers’ Eyes?
American Academy of Ophthalmology (AAO)

A study published in Obstetrics and Gynecology suggests that pre-eclampsia may be associated with retinal disease in the mother later in life. Pre-eclampsia is a pregnancy complication characterized by high blood pressure and large amounts of protein in the urine. According to this study, more severe and earlier-onset pre-eclampsia was associated with even higher risk.

Released: 28-Feb-2017 8:05 AM EST
FSU Researcher to Lead U.S. - Russia Project on Health, Space Travel
Florida State University

A Florida State University researcher will lead a joint U.S.-Russia project that will examine the effect of space travel on astronauts’ vision, an ongoing problem that NASA has been eager to solve.

   
Released: 28-Feb-2017 5:05 AM EST
Queen’s Researchers Collaborate with Guide Dogs NI to Pioneer New Study for Children with Sight Loss
Queen's University Belfast

Researchers from Queen's University Belfast collaborate with Guide Dogs NI on a new research study to understand the impact of sight loss on how early movement develops in children with a vision impairment.

   
Released: 27-Feb-2017 5:05 PM EST
NeuroVision Announces Participation in Landmark Alzheimer’s A4 Study Evaluating Its Novel Retinal Imaging Technology
PR Pacific

NeuroVision Imaging LLC (“NeuroVision”) today announced its participation in a new substudy with investigators at the University of California San Diego School of Medicine (UC San Diego) and the University of Southern California (USC) to be part of the landmark Anti-Amyloid Treatment in Asymptomatic Alzheimer’s (or “A4”) clinical trial. The purpose of the A4 study is to test whether a new investigational treatment that may reduce beta-amyloid accumulation in the brain can also slow memory loss caused by Alzheimer’s disease.

   


close
1.5507